Shire Submits Elaprase BLA For Hunter Syndrome
This article was originally published in The Pink Sheet Daily
Executive Summary
Orphan therapy would be first human enzyme replacement therapy for the genetic disorder.
You may also be interested in...
Shire’s Hunter Syndrome Treatment Elaprase Gets European Approval
Enzyme replacement therapy will launch in most countries this year as pricing and reimbursement are negotiated.
Shire’s Hunter Syndrome Treatment Elaprase Gets European Approval
Enzyme replacement therapy will launch in most countries this year as pricing and reimbursement are negotiated.
Shire’s Elaprase Approved For Hunter Syndrome
The company plans to launch the orphan enzyme replacement therapy within 30 days.